1620 Investment Advisors, Inc. Adial Pharmaceuticals, Inc. Transaction History

1620 Investment Advisors, Inc.

  • $126 Million
  • Q4 2024

A detailed history of 1620 Investment Advisors, Inc. transactions in Adial Pharmaceuticals, Inc. stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 3,600 shares of ADIL stock, worth $2,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,600
Holding current value
$2,664
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$0.95 - $1.23 $3,420 - $4,428
3,600 New
3,600 $3,000

Others Institutions Holding ADIL

# of Institutions
2
Shares Held
9.1K
Call Options Held
0
Put Options Held
0
View Full List

About ADIAL PHARMACEUTICALS, INC.

ADIL Quotes by TradingView
  • Ticker ADIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,854,000
  • Market Cap $19.9M
  • Description
  • Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...
More about ADIL
Track This Portfolio

Track 1620 Investment Advisors, Inc. Portfolio

Follow 1620 Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1620 Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on 1620 Investment Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email